1. Home
  2. EOLS vs PKST Comparison

EOLS vs PKST Comparison

Compare EOLS & PKST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EOLS
  • PKST
  • Stock Information
  • Founded
  • EOLS 2012
  • PKST 2008
  • Country
  • EOLS United States
  • PKST United States
  • Employees
  • EOLS N/A
  • PKST N/A
  • Industry
  • EOLS Biotechnology: Pharmaceutical Preparations
  • PKST Real Estate Investment Trusts
  • Sector
  • EOLS Health Care
  • PKST Real Estate
  • Exchange
  • EOLS Nasdaq
  • PKST Nasdaq
  • Market Cap
  • EOLS 406.9M
  • PKST 470.2M
  • IPO Year
  • EOLS 2018
  • PKST N/A
  • Fundamental
  • Price
  • EOLS $6.37
  • PKST $12.51
  • Analyst Decision
  • EOLS Strong Buy
  • PKST Strong Buy
  • Analyst Count
  • EOLS 4
  • PKST 2
  • Target Price
  • EOLS $21.25
  • PKST $17.50
  • AVG Volume (30 Days)
  • EOLS 1.0M
  • PKST 205.9K
  • Earning Date
  • EOLS 11-05-2025
  • PKST 10-29-2025
  • Dividend Yield
  • EOLS N/A
  • PKST 3.12%
  • EPS Growth
  • EOLS N/A
  • PKST N/A
  • EPS
  • EOLS N/A
  • PKST N/A
  • Revenue
  • EOLS $277,941,000.00
  • PKST $223,891,000.00
  • Revenue This Year
  • EOLS $13.68
  • PKST N/A
  • Revenue Next Year
  • EOLS $27.96
  • PKST N/A
  • P/E Ratio
  • EOLS N/A
  • PKST N/A
  • Revenue Growth
  • EOLS 17.15
  • PKST N/A
  • 52 Week Low
  • EOLS $5.71
  • PKST $10.14
  • 52 Week High
  • EOLS $17.82
  • PKST $14.80
  • Technical
  • Relative Strength Index (RSI)
  • EOLS 45.10
  • PKST 34.89
  • Support Level
  • EOLS $5.92
  • PKST $12.80
  • Resistance Level
  • EOLS $6.42
  • PKST $13.73
  • Average True Range (ATR)
  • EOLS 0.24
  • PKST 0.42
  • MACD
  • EOLS 0.05
  • PKST -0.10
  • Stochastic Oscillator
  • EOLS 70.55
  • PKST 3.75

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

About PKST Peakstone Realty Trust

Peakstone Realty Trust is an internally managed, publicly registered real estate investment trust (REIT) that owns and operates predominately single-tenant industrial and office properties with creditworthy tenants and long-term leases. Peakstone's portfolio consists of newer vintage, and well-located real estate assets in majorly high-growth coastal and sunbelt markets. The company has two reportable segments: Industrial and Office. The Industrial segment consists of industrial outdoor storage properties which have a low building-to-land ratio, or low coverage, maximizing yard space for the display, movement, and storage of materials and equipment. The Office segment includes office, R&D and data center properties.

Share on Social Networks: